MHRA Archives - Haemosexual

ALERT: ISSUE IDENTIFIED IN BPL PLASMA PRODUCTS PRODUCTION

19th July 2017 Mark Ward

ISSUE IDENTIFIED IN BPL PLASMA PRODUCTS PRODUCTION 19TH JULY 2017 JEFFERSON COURTNEY The Department of Health (DH) published a statement (below) this morning regarding an issue identified during a routine inspection of Bio Products Laboratory (BPL) and their production of plasma derived blood products. The statement says that there was a problem with the computer software which controls the […]

NEWS: Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

6th February 2017 Mark Ward

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation 03 February 2017 New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be […]